Paper3787261
Catalytic antibodies.
Tramontano A and 2 others. Science, 1986. Cited by 417 papers, by iCite.
Cite this record
ConductScience Library. Catalytic antibodies. Papers, record 3787261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3787261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Catalysis | Major topic |
| Binding Sites | |
| Carboxylic Ester Hydrolases | |
| Chemical Phenomena | |
| Chemistry | |
| Esters | |
| Haptens | |
| Hydrolysis | |
| Kinetics |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM35318 | NIGMS NIH HHS | United States | PubMed |
Source PubMed
Cited by94
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 417 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796707 | ACE2-like Catalytic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies. | Pathogens | 2026 | https://conductscience.org/library/papers/42796707 | PubMed |
| 42159430 | Nanozymes for Advanced Hemoglobin-Based Oxygen Carriers: Applications in Blood Substitution, Wound Healing, Antitumor Therapy, and Beyond. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42159430 | PubMed |
| 41441690 | Anti-Idiotypic Antibodies in Immune Regulation and Disease: Therapeutic Promise for Next-Generation Vaccines. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41441690 | PubMed |
| 40707464 | Nanozymes expanding the boundaries of biocatalysis. | Nat Commun | 2025 | https://conductscience.org/library/papers/40707464 | PubMed |
| 40693778 | ACE-2-like enzymatic activity in COVID-19 convalescents with persistent pulmonary symptoms associated with immunoglobulin. | mBio | 2025 | https://conductscience.org/library/papers/40693778 | PubMed |
| 38501835 | ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients. | mBio | 2024 | https://conductscience.org/library/papers/38501835 | PubMed |
| 38353665 | Strategies for designing biocatalysts with new functions. | Chem Soc Rev | 2024 | https://conductscience.org/library/papers/38353665 | PubMed |
| 38064411 | Catalytic Protein Inhibitors. | Angew Chem Int Ed Engl | 2024 | https://conductscience.org/library/papers/38064411 | PubMed |
| 37428919 | Decoupling of catalysis and transition state analog binding from mutations throughout a phosphatase revealed by high-throughput enzymology. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37428919 | PubMed |
| 35650353 | The road to fully programmable protein catalysis. | Nature | 2022 | https://conductscience.org/library/papers/35650353 | PubMed |
| 35409256 | Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409256 | PubMed |
| 34126576 | Incorporation of a FRET pair within a phosphonate diester. | Bioorg Chem | 2021 | https://conductscience.org/library/papers/34126576 | PubMed |
| 34070542 | Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside. | Biomedicines | 2021 | https://conductscience.org/library/papers/34070542 | PubMed |
| 32751323 | Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32751323 | PubMed |
| 32232151 | A new algorithm to convert a normal antibody into the corresponding catalytic antibody. | Sci Adv | 2020 | https://conductscience.org/library/papers/32232151 | PubMed |
| 31783036 | Catalytic antibody (catabody) platform for age-associated amyloid disease: From Heisenberg's uncertainty principle to the verge of medical interventions. | Mech Ageing Dev | 2020 | https://conductscience.org/library/papers/31783036 | PubMed |
| 31387945 | A strategy for the selection of monovalent antibodies that span protein dimer interfaces. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31387945 | PubMed |
| 30823659 | Molecular Diversity Required for the Formation of Autocatalytic Sets. | Life (Basel) | 2019 | https://conductscience.org/library/papers/30823659 | PubMed |
| 30629599 | Crystal structure of a Thermus aquaticus diversity-generating retroelement variable protein. | PLoS One | 2019 | https://conductscience.org/library/papers/30629599 | PubMed |
| 28229960 | What history tells us XLII. A 'new' view of proteins. | J Biosci | 2017 | https://conductscience.org/library/papers/28229960 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3787261
GET https://conductscience.org/api/papers/v1/3787261/cited_by?page=2